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ABSTRACT: Cigarette smoking is known to be a major risk factor for pancreatic cancer 
and pancreatitis is believed to be a predisposed condition for pancreatic cancer. As of this 
date, there is no established experimental animal model to conduct detailed studies on these 
two deadly diseases. Our aim is to establish a rodent model by which we can systematically 
study the pathogenesis of pancreatitis and pancreatic cancer. Methods: Adult Male Sprague 
Dawley rats were exposed to graded doses of nicotine by various routes for periods of three 
to 16 weeks. Blood samples were measured for hormonal and metabolic parameters. The 
pancreas was evaluated for histopathological changes and its function was assessed in iso-
lated pancreatic acini upon stimulation with cholecystokinin (CCK) or carbachol (Cch). The 
pancreatic tissue was evaluated further for oncogene expression. Results: Body weight, food 
and fluid intakes, plasma glucose and insulin levels were significantly reduced in animals 
with nicotine exposure when compared to control. However, CCK and gastrin levels in the 
blood were significantly elevated. Pancreatic function was decreased significantly with no 
alteration in CCK receptor binding. Pancreatic histology revealed vacuolation, swelling, 
cellular pyknosis and karyorrhexis. Mutant oncogene, H-ras, was overexpressed in nicotine-
treated pancreatic tissue. Summary and conclusions: The results suggest that alterations in 
metabolic, hormonal and pathologic parameters following nicotine-treatment appear consis-
tent with diagnostic criteria of human pancreatitis. It is proposed that rats could be consid-
ered as a potential animal model to study the pathogenesis of pancreatitis. 
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INTRODUCTION 
 
Use of tobacco products, cigarettes and smokeless 
tobacco continues to be a major health problem in the 
United States and the world. Socio-economic and ge-
netic factors may contribute to this problem [1,3,4]. It 
has been reported that an estimated 3 million deaths 
occur worldwide due to tobacco use [2]. Among the 
various components present in the tobacco products, 
nicotine and the dependency on it, appears to be the 
primary reason for the compulsive smoking behavior by 
smokers [5].  Therefore it may be surmised that nicotine 
is, at least partly responsible or may contribute as a 
major risk factor for pathogenesis of varieties of disor-
ders in smoking population. The pathophysiological 
effects of smoking and nicotine on the pancreas have 
recently been reviewed [6]. 
Our current investigation focuses primarily on the 
exploration of the development of an animal model to 
study the development of two major pancreatic dis-
eases, pancreatitis and pancreatic cancer, in response to 
nicotine exposure. 
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Animals: 
Rats were used as the experimental model. The 
Institutional Animal Care and Use Committee at the 
University of Arkansas for Medical Sciences approved 
the protocols for the study. The animal study protocol 
followed the strict guidelines published by the Ameri-
can Physiological Society under Animal Welfare Act. 
All animals were procured two weeks prior to study, 
acclimatized with environmental conditions under 
12/12 light dark cycle before being exposed to nicotine. 
 
Exposure conditions: 
Animals were weighed prior to being subjected to 
nicotine exposure. The animals were exposed to graded 
doses of nicotine for various lengths of time by three 
routes of administration (aerosol, intragastric and ad-lib 
drinking water). For example, while exposure by drink-
ing water ad-libitum continued for 12 to 16 weeks, ex-
posure by aerosol continued for 3 weeks with 1hour 
daily exposure in the aerosol chamber. In contrast, nico-
tine given via intragastric administration by gavage 
feeding continued for 120 days with one administration 
per day. In all groups, consumption of daily food and 
fluid intake were measured. In all studies indicated, a 
paired identical control group, which was not exposed 
to nicotine, was taken for comparison. For each study, 
6-8 animals per group were used. 
At term, all animals were anesthetized with a 
mixture of ketamine hydrochloride and acyl-promazine 
mixture [(10:1 v/v) : 0.1 ml per 100 g body weight)] 
and sacrificed by exsanguinations. Blood was collected 
in tubes containing heparin (10 ul, 10,000 units) and 
trasylol (10ul, 100 KIE Units/ml). The blood was kept 
in ice until centrifuged at 3000 rpm. Plasma was sepa-
rated and stored at –20°C for future analysis.  
An abdominal incision was made to expose the 
pancreas. The pancreas was removed carefully, freed of 
fat and lymphatic vessels. A segment of the pancreas 
was fixed in 10% formalin in phosphate buffer, pH 7.4 
for histopathological evaluation using the criteria pub-
lished earlier by others [7-11]. The remaining pancreas 
was used for the isolation of acinar cells by the methods 
published previously by others and by us [12,13]. The 
isolated acinar cells were purified by differential cen-
trifugation. Integrity of the pancreas (pancreatic func-
tion) was assessed by determining the ability of acinar 
cells to release amylase in response to graded doses of 
cholecystokinin. 
 
Assays:  
Plasma samples were assayed for gastrin, chole-
cystokinin and insulin by radioimmunoassays devel-
oped either in our laboratory or using the commercial 
kit [14,15]. Glucose levels were measured in the plasma 
by O-toluidine method [16]. Amylase release from the 
acinar cells was measured by employing procion yellow 
starch as substrate [17]. Protein concentration was de-
termined by the method of Bradford [18]. CCK receptor 
assays were conducted in isolated acinar cell mem-
branes using 
125I-BH-CCK-8 employing the methods 
described by Steigerwalt and Williams [19]. CCK re-
ceptor affinity (Kd) and CCK receptor capacity (Bmax) 
were calculated from a Scatchard Plot developed by 
radio-ligand binding assay [20,21].  
Oncogene expression and mutation was deter-
mined in fixed pancreatic tissues. DNA was isolated by 
enzyme digestion, amplified by polymerase chain reac-
tion. Following electrophoresis and transfer to nylon 
filters, the filters were probed with 
32P-cDNA-H-ras  
(0.8 kb) and K-ras (0.39 kb). For ras mutation experi-
ments amplified PCR fragments obtained from codons 
12, 13 and 61 were applied to prefixed nylon filters 
following denaturation at 95°C for 3 min. The filters 
were crosslinked using UV light, prehybridized and 
hybridized with specific radiolabeled oligonucleotides 
for each mutations at codons 12, 13 and 61. The filters 
were washed and analyzed on a betagen betascope 
autoradiography [22].  
 
Calculations: 
Data from different studies were summarized in 
the Results section. Comparison of the dataset between 
the groups was analyzed by student’s t test or analysis 
of variance (ANOVA). A p value of less than 0.05 was 
considered statistically significant. 
 
SUMMARY OF RESULTS: 
 
Body weights of the animals exposed to nicotine 
were significantly lower than the control animals at the 
time of sacrifice. Changes in metabolic parameters 
measured as an index of plasma glucose and insulin 
levels were significantly reduced in nicotine-treated 
groups than the control.  However, the hormonal pa-
rameters (gastrin and CCK) were significantly elevated 
in nicotine-treated group as compared to control group. 
Histopathological evaluation of the formalin fixed 
pancreatic tissues of the control animals indicated no 
gross ultrastructural changes. The pancreatic tissues 
from the nicotine exposed animals, however, revealed 
cytoplasmic swelling and vacuolation, pyknotic nuclei 
and karyorrhexis (fragmentation of nuclei). These pa-
thologies remained strictly localized in the exocrine 
tissues of the pancreas. 
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Acinar cell bioassay experiments conducted with 
cells isolated from the control group in the presence of 
graded doses of CCK showed maximal stimulation of 
amylase release at a dose of 10
-10M. The dose response 
curve shifted down to the right when repeated on acinar 
cells isolated from nicotine-treated animals. The maxi-
mal stimulated response by acinar cells isolated from 
nicotine-treated group was decreased significantly by as 
much as 50% from the control. There was no difference 
in total cellular amylase content (U amylase/mg of pro-
tein) between the two groups. The net retention of amy-
lase following its release was higher in nicotine group 
as compared to control group. 
There was no change in the acinar membrane 
binding parameters for CCK receptors between control 
and nicotine exposed groups. The changes in Kd and 
Bmax for CCK receptors between the two groups were 
not significantly different. 
Oncogene studies indicated that both wild and 
mutant type oncoproteins were expressed in the pancre-
atic tissue. Frequency of mutations was higher in tis-
sues from nicotine-treated rats when compared to that 
of control. DNA analysis of H-ras gene with amplifica-
tions of codons 12, 13 and 61 showed a specific muta-
tion on codon 61 at glutamine of H-ras gene. 
 
DISCUSSION: 
 
Reduction of body weights of animals exposed to 
nicotine is a complex event and perhaps regulated by 
increased energy utilization as reflected by the de-
creased plasma levels of glucose and insulin. It has 
been shown that smokers increase their energy utiliza-
tion by increasing the basal metabolic rate [23,24]. 
Coupling with this observation is the decreased food 
intake that may have partly been influenced by high 
levels of endogenous CCK, which was shown to regu-
late the food intake [25]. 
Histopatholgical alterations noted in nicotine 
treated animals were consistent with the observations 
reported by other investigators in rats and other species 
[7-11] that indicates an earliest sign of the development 
of acute pancreatitis. Although cigarette smoking has 
been linked to chronic pancreatitis (6), the role of nico-
tine in this phenomenon has not been defined. The fu-
ture directions of the study should implicate into the 
long-term pathological effects of nicotine on both exo-
crine and endocrine pancreas. The time course and dose 
dependent changes of pancreatic morphology from ini-
tiation to final development of pancreatitis need to be 
examined. 
 
Functional changes of the pancreas in response to 
nicotine exposure were measured in isolated acinar 
cells with secretagogues that are known to stimulate the 
release of amylase or other enzymes [12,13]. A signifi-
cant reduction of pancreatic function was noted with 
nicotine treatment that is consistent with the observa-
tions noted in patients with acute or chronic pancreatitis 
[8-11]. Similar loss of pancreatic function was reported 
in acute pancreatitis induced in other species by 
caerulein or choline deficient ethionine (CDE) diet [8-
10]. Since no changes in CCK receptor affinity and 
capacity were noted in acinar membranes isolated from 
control and nicotine treated rats, it appears that loss of 
pancreatic function may have been associated with 
post-receptor mediated process.  
Gene and point mutation studies on the pancreatic 
tissues indicated that nicotine exposure induced the 
activation and mutation of Ha-ras oncogene. Ras muta-
tions have been implicated in many human cancers 
particularly in pancreatic cancers [26,27]. Activated K-
ras gene has been noted in approximately 90% of hu-
man pancreatic carcinomas [27-29]. In a recent study 
with 97 Brazilian patients with pancreatic ductal adeno-
carcinoma, pancreatic neuroendocrine tumors and 
chronic pancreatitis, a K-ras mutation at codon 12 was 
found notably present in malignancies but absent in 
chronic pancreatitis and pancreatic neuroendocrine tu-
mors [30]. The authors suggest consideration of the 
possibility of the treatment strategy for this oncogene in 
the future.  
The data from our animal studies show a correla-
tion between pathological, functional and molecular 
changes of the exocrine pancreatic tissue with nicotine 
exposure. These changes appear to reflect to some ex-
tent the pathophysiological events in acute pancreatitis. 
Using the time and duration of nicotine exposure as 
guides, the early phase and progression of induced pan-
creatic pathophysiological events can be documented, 
controlled and appropriate intervention may be insti-
tuted. The rodents may therefore be considered as a 
potential model for acute pancreatitis development fol-
lowing nicotine exposure and thus should be further 
explored. 
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